Your Messages Inbox
Your Article Summary
See Latest ArticlesMerck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for AFLURIA, Seasonal Influenza Vaccine from CSL Biotherapies
Merck & Co., 09/29/09
Merck & Co., Inc. announced that the Company has entered into an exclusive agreement with CSL Biotherapies, a subsidiary of CSL Limited, to market and distribute AFLURIA, CSL's seasonal influenza vaccine, in the U.S., for the 2010/2011–2015/2016 flu seasons. CSL and Merck have been partners in vaccine development and marketing since 1980.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Go Go Generics
PharmExec, 12/18/09
MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09
Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977
Forest Laboratories, 12/18/09
Article Search
Sponsor